UBS Group
BHST

UBS Group’s BioHarvest Sciences BHST Stock Holding History

UBS Group’s Portfolio BHST Stock Details BHST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$495 Sell
173
-456
-72% -$1.74K ﹤0.01% 9827
2026
Q1 		$2.73K Sell
629
-544
-46% -$2.56K ﹤0.01% 9212
2025
Q4 		$6.09K Buy
+1,173
New +$9.38K ﹤0.01% 8587

Other funds holding BHST

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $1.05B AUM 22.99% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

UBS Group's BHST Position: Q2 2026 in Review

UBS Group reduced its BioHarvest Sciences (BHST) stake by 72% in Q2 2026, selling an estimated $1.74K and leaving 173 shares worth $495. The position accounts for ﹤0.01% of the portfolio, ranked #9827.

UBS Group first reported a position in BHST in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.09K in Q4 2025. 19 funds tracked by Wall St. Rank hold BHST as of Q2 2026.

  • UBS Group held 173 shares of BioHarvest Sciences worth $495 as of Q2 2026.
  • UBS Group sold 456 BioHarvest Sciences shares in Q2 2026, an estimated $1.74K.
  • BioHarvest Sciences made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9827 holding.
  • UBS Group first reported a position in BioHarvest Sciences in Q4 2025 and has held it in 3 quarters since.
  • UBS Group's BioHarvest Sciences position peaked at $6.09K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held BioHarvest Sciences as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.